Not exact matches
Institute researchers Dr Ashley Ng, Dr Maria Kauppi, Professor Warren Alexander, Professor Don Metcalf and colleagues from the institute's Cancer and
Haematology and Molecular Medicine divisions led the research, published in the
journal Proceedings of the National Academy of Sciences.
A new test may reveal which patients will respond to treatment for graft versus host disease (GVHD), an often life - threatening complication of stem cell transplants (SCT) used to treat leukemia and other blood disorders, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai and published online today in the
journal Lancet
Haematology and in print in the January issue.
In a study recently published in the
journal Experimental
Haematology, the group demonstrate that is wide variation in BCR - ABL expression levels in the cell model and the stickier cells have a higher level of BCR - ABL expression.
The
journal's contribution to advancing the field of
haematology is the reason why it is read by haematologists, clinical pharmacologists, cardiologists, surgeons, internal specialists and laboratory physicians